CRISPR/Cas9 Market

CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

CRISPR/Cas9 Market contains market size and forecasts of CRISPR/Cas9 in Global, including the following market information:

Global CRISPR/Cas9 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CRISPR/Cas9 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Genome Editing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CRISPR/Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the CRISPR/Cas9 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CRISPR/Cas9 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CRISPR/Cas9 Market Segment Percentages, by Type, 2021 (%)

Genome Editing

Genetic Engineering

gRNA Database/Gene Librar

CRISPR Plasmid

Human Stem Cells

Genetically Modified Organisms/Crops

Cell Line Engineering

Global CRISPR/Cas9 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CRISPR/Cas9 Market Segment Percentages, by Application, 2021 (%)

Biotechnology Companies

Pharmaceutical Companies

Academic Institutes

Research and Development Institutes

Global CRISPR/Cas9 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CRISPR/Cas9 Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CRISPR/Cas9 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CRISPR/Cas9 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Caribou Biosciences

Integrated DNA Technologies(IDT)

CRISPR Therapeutics

Merck

Mirus Bio

Editas Medicine

Takara Bio

Thermo Fisher Scientific

Horizon Discovery Group

Intellia Therapeutics

Agilent Technologies

Cellecta

GenScript

GeneCopoeia

Synthego